Literature DB >> 2694257

Chemotherapy of renal cell carcinoma: 1983-1989.

A Yagoda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2694257

Source DB:  PubMed          Journal:  Semin Urol        ISSN： 0730-9147


× No keyword cloud information.
  10 in total

Review 1.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

Review 2.  Tumors of the kidney, ureter, and bladder.

Authors:  W A See; R D Williams
Journal:  West J Med       Date:  1992-05

3.  High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma.

Authors:  E K Seaman; S Ross; I S Sawczuk
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trial.

Authors:  R T Zon; J McClean; D Helman; R Ansari; J Picus; A Sandler; S D Williams; P J Loehrer
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

5.  Effects of cytokines on growth in vitro of primary human renal cell carcinoma.

Authors:  W de Riese; E P Allhoff; M Werner; C G Stief; S Liedke; H Kirchner; J Atzpodien
Journal:  Urol Res       Date:  1992

6.  Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma.

Authors:  Anil K Kapoor; Sébastien J Hotte
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

7.  Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alpha.

Authors:  L Canobbio; A Rubagotti; L Miglietta; D Cannata; A Curotto; D Amoroso; F Boccardo
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

Authors:  Chiara Mignogna; Stefania Staibano; Vincenzo Altieri; Gaetano De Rosa; Giuseppe Pannone; Angela Santoro; Rosanna Zamparese; Massimino D'Armiento; Romualdo Rocchetti; Ernesto Mezza; Mario Nasti; Viviana Strazzullo; Vittorino Montanaro; Massimo Mascolo; Pantaleo Bufo
Journal:  BMC Cancer       Date:  2006-12-19       Impact factor: 4.430

9.  Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients.

Authors:  T Philip; S Negrier; C Lasset; B Coronel; M Bret; J Y Blay; Y Merrouche; C Carrie; P Kaemmerlen; F Chauvin
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

10.  Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines.

Authors:  Y Mizutani; B Bonavida; O Yoshida
Journal:  Urol Res       Date:  1994
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.